APA (7th ed.) Citation

Dhakal, B., D'Souza, A., Arce-Lara, C., Pasquini, M., Saber, W., Falvo, F., . . . Hamadani, M. (2015). Superior efficacy but higher cost of plerixafor and abbreviated-course G-CSF for mobilizing hematopoietic progenitor cells (HPC) in AL amyloidosis. Bone Marrow Transplantation, 50(4), 610. https://doi.org/10.1038/bmt.2014.318

Chicago Style (17th ed.) Citation

Dhakal, B., et al. "Superior Efficacy but Higher Cost of Plerixafor and Abbreviated-course G-CSF for Mobilizing Hematopoietic Progenitor Cells (HPC) in AL Amyloidosis." Bone Marrow Transplantation 50, no. 4 (2015): 610. https://doi.org/10.1038/bmt.2014.318.

MLA (9th ed.) Citation

Dhakal, B., et al. "Superior Efficacy but Higher Cost of Plerixafor and Abbreviated-course G-CSF for Mobilizing Hematopoietic Progenitor Cells (HPC) in AL Amyloidosis." Bone Marrow Transplantation, vol. 50, no. 4, 2015, p. 610, https://doi.org/10.1038/bmt.2014.318.